NCT06286644 Hop Compounds on the Immune System (VH)
| NCT ID | NCT06286644 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Vienna |
| Condition | Inflammatory Response |
| Study Type | INTERVENTIONAL |
| Enrollment | 14 participants |
| Start Date | 2022-05-30 |
| Primary Completion | 2025-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 14 participants in total. It began in 2022-05-30 with a primary completion date of 2025-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the present study is to determine the effect of Iso-alpha-Acids and Xanthohumol from hops on the immune response of healthy participants over a timeframe of 6 hours.
Eligibility Criteria
Inclusion Criteria: * healthy * BMI: \>18,5 kg/m² or \<30 kg/m² Exclusion Criteria: * food intolerances * food allergies * chronic inflammatory diseases * metabolic diseases * viral or bacterial infections within the last 3 weeks of inclusion * intake of immunosuppressive medication
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06286644 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Inflammatory Response. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06286644 currently recruiting?
Yes, NCT06286644 is actively recruiting participants. Contact the research team at ina.bergheim@univie.ac.at for enrollment information.
Where is the NCT06286644 trial being conducted?
This trial is being conducted at Vienna, Austria.
Who is sponsoring the NCT06286644 clinical trial?
NCT06286644 is sponsored by University of Vienna. The trial plans to enroll 14 participants.